Certificate of Analysis (COA) View the laboratory certificate for this product [ View COA ]

Pure KLOW Stack 80mg

R 1,450.00
Add to WishlistCompare

KLOW Stack 80mg — Research-Grade Peptide Blend

KLOW Stack 80mg is a multi-peptide research formulation supplied by Pure Performance Labs as lyophilised material for controlled laboratory and scientific research. The formulation combines GHK-Cu, BPC-157, TB-500 and KPV in a defined 80mg total presentation.

This product is supplied strictly for research purposes and is not intended for human or veterinary use.

Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.

Research Overview

KLOW Stack is a four-peptide research blend comprising GHK-Cu, BPC-157, TB-500 and KPV. Each component has been investigated independently in laboratory research involving cellular signalling, tissue biology, extracellular-matrix research and inflammatory pathways.

The complete KLOW formulation should be regarded as a research blend. Research findings involving individual components should not be interpreted as evidence establishing the efficacy or safety of the complete combination.

Composition

• GHK-Cu: 50mg
• BPC-157: 10mg
• TB-500: 10mg
• KPV: 10mg
• Total peptide content: 80mg
• Format: Lyophilised powder
• Supplier: Pure Performance Labs
• Research category: Skin, Tissue & Peptide Research
• Intended use: Laboratory research only

Research Context

Researchers may investigate the individual components of KLOW Stack in controlled experimental models involving cellular signalling, tissue biology, extracellular-matrix processes and inflammatory research. Experimental design, analytical methodology and laboratory procedures should be determined by appropriately qualified researchers.

Product Information

KLOW Stack is a combination of four distinct research peptides rather than a single molecular compound. Researchers should refer to the applicable batch documentation and product specifications when conducting laboratory work.

Research-Use Notice

This product is supplied strictly for laboratory and scientific research purposes. It is not intended for human consumption, self-administration, diagnosis, treatment, prevention or veterinary use.

Key Features

• Multi-compound research formulation
• Designed for laboratory investigation of combined peptide and biochemical components
• Suitable for controlled research applications
• 80mg research presentation
• Supplied for research purposes only

Dosage & Usage

REFERENCE RECONSTITUTION INFORMATION

This guide explains how research peptides are commonly reconstituted using bacteriostatic water (BAC water), and shows how dosing volumes correspond to syringe units.Always follow sterile preparation techniques when handling research peptides.

Always follow sterile preparation techniques when handling research peptides.

⚠️ DISCLAIMER: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

General Preparation

⚠️ Important: Allow product vial and BAC water to reach room temperature before reconstituting to reduce condensation uptake

  • Use bacteriostatic water (BAC water) only
  • Inject water slowly down the inside of the vial
  • Do not shake the vial
  • Gently swirl to dissolve the peptide powder
  • Store refrigerated after mixing
  • Use sterile technique when handling

Reference Handling Information

Reference information for laboratory handling of MOTS-c.

RouteSubcutaneous injectionSchedule2–3 times per week subcutaneous injectionsInjection SitesRotate injection sites (abdomen, thighs, upper arms)DosingDose Range: 2.5–10 mg per injection, 2–3 times weekly

  • Use sterile technique when handling and administering
  • Cycle Length: 4–8 weeks
  • Goal: Support metabolic function, insulin sensitivity, and energy regulation
  • Timing: Any consistent time, 2–3 times per week
  • Storage - Lyophilized: Store at −20 °C in dry, dark conditions
  • Storage - Reconstituted: Refrigerate at 2–8 °C; use within 7–14 days for optimal potency
  • Allow vial to reach room temperature before opening

MOTS-c (40mg) - RECONSTITUTION TABLES

Dosing Protocol (2 mL BAC Water; ~20 mg/ml)

2-3 times weeklyDose Per InjectionUnits (per injection) (ml)Low2.0 mg10 units (0.10ml)Moderate3 mg15 units (0.15ml)High4.0 mg20 units (0.20ml)Max8 mg40 units (0.40ml)Reference interval:2-3 times weekly subcutaneous injection. Goal: Support metabolic function, insulin sensitivity, and energy regulation.These parameters are drawn from published research for reference purposes only. They do not constitute medical or dosing advice. For laboratory research only.

Dosing Protocol (3 mL BAC Water; ~13.33 mg/ml)

2-3 times weeklyDose Per InjectionUnits (per injection) (ml)Low2.0 mg15 units (0.15ml)Moderate3 mg23 units (0.23ml)High4.0 mg30 units (0.30ml)Max8 mg60 units (0.60ml)Reference interval:2-3 times weekly subcutaneous injection. Goal: Support metabolic function, insulin sensitivity, and energy regulation.These parameters are drawn from published research for reference purposes only. They do not constitute medical or dosing advice. For laboratory research only.

FAQ's & Tips

FAQ

What is KLOW Stack?
KLOW Stack is a proprietary research peptide blend containing KPV, BPC-157 and TB-500.

What is the reference strength?
The PURE Labs listing specifies an 80 mg reference strength.

What peptides are included?
The listed formulation is KPV + BPC-157 + TB-500.

What is KLOW Stack researched for?
Its individual components are investigated in areas including peptide biology, cellular signalling, inflammatory pathways and tissue-related research.

Is KLOW Stack intended for human use?
No. This product is supplied strictly for laboratory and scientific research and is not intended for human or animal consumption.

Research

KLOW Stack is a multi-component research blend containing GHK-Cu, BPC-157, TB-500 and KPV. Its research rationale draws on separate literature for GHK-Cu and thymosin beta-4-related pathways, BPC-157 preclinical research, and KPV studies of inflammatory signalling. Direct evidence for the combined KLOW formulation is limited; component-level findings should not be interpreted as proof that the blend produces additive or synergistic effects. For laboratory research use only.

Reviews